Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Thursday 24 June 2021 4:19 pm  |  Updated:  Thursday 24 June 2021 4:20 pm

Brain damage in people who die from Covid-19 identical to Alzheimer’s and Parkinson’s

By: Michiel Willems

Add as a preferred source on Google
mental health
Bafflingly, the researchers did not detect any evidence of the virus itself inside the brain.

The brains of people who died as a result of Covid-19 show such a degree of inflammation that they are nearly identical to those in patients who passed away as a result of Alzheimer’s disease or Parkinson’s.

Even though none of the patients reported signs of brain impairment in the runup to their death, researchers at the Stanford School of Medicine and Saarland University in Germany found “profound markers of inflammation” in the patients’ brain tissue, identical to what medics would expect expect to see in the brains of Alzheimer’s and Parkinson’s deaths.

Not inside the brain

Bafflingly, they did not detect any evidence of the virus itself inside the brain, according to the study, which was published in the journal Nature earlier this week.

Determining whether or not the Coronavirus is present in the brain is important because it can help researchers understand whether or not it is the virus itself — or the body’s immune response to the virus — that is causing the damage.

The researchers pointed out this understanding is critical for making the best decision when it comes to treatment.

The Stanford and Saarland teams examined the brain tissue of eight people who died of Covid-19 and compared this to the brains of 14 people who died of Alzheimer’s disease or Parkinson’s.

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Corona Impact Series
  • Coronavirus

Trending Articles

  • James Watt offers to buy back Brewdog

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • Brewdog owner shrugs off James Watt takeover bid

  • Bank of England warns Burnham of UK economy’s ‘big issue’

  • UK’s biggest pub firm probed over treatment of tenants

More from City PM

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire
  • Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

    Business Wire
  • Alkermes to Report Second Quarter Financial Results on July 28, 2026

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook